CJC-1295 with DAC – Comprehensive Research Overview (2026)
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH 1-29). The addition of the DAC moiety allows strong, reversible binding to serum albumin, dramatically extending its half-life. This creates sustained elevation of growth hormone (GH) and IGF-1 levels, making it one of the most convenient research peptides for body composition, recovery, and anti-aging protocols. It is frequently stacked with GHRPs such as Ipamorelin for synergistic effects.
→ View CJC-1295 with DAC (for laboratory research use only)
Chemical Structure and Properties
- Amino Acid Sequence: Modified GHRH (1-29) with key substitutions for DPP-4 resistance and a DAC (Drug Affinity Complex) attached to a lysine residue.
- Molecular Weight: ≈3,647 Da
- Form: Lyophilized powder for subcutaneous injection
- Key Feature: Extended half-life (~6–8 days) due to albumin binding, enabling infrequent dosing.
Mechanism of Action
CJC-1295 with DAC binds to GHRH receptors on pituitary somatotrophs, stimulating both GH synthesis and release.
- Provides sustained elevation of baseline GH and IGF-1 levels rather than sharp pulses.
- Maintains some natural pulsatility while offering continuous signaling.
- Works synergistically with ghrelin mimetics (GHRPs) to amplify overall GH output.
- Preserves natural feedback mechanisms better than high-dose exogenous GH.
Clinical Evidence and Research Findings
Early Phase 1/2 clinical studies demonstrated sustained increases in GH and IGF-1 lasting up to 6–10 days after a single dose. While large Phase 3 trials for body composition or anti-aging are lacking, CJC-1295 with DAC has extensive anecdotal and clinical use in wellness and performance research. It is often chosen when users prefer fewer injections compared to daily pulsing protocols.
→ Interested in researching CJC-1295 with DAC? View Product Options
Benefits (Research & Clinical Observations)
- Increased lean muscle mass and strength
- Enhanced fat loss and improved body composition
- Faster recovery from training and injury
- Better sleep quality and skin elasticity
- Convenient dosing schedule (1–2 times per week)
Typical Dosing Protocols (Off-Label / Compounded)
- Common protocols: 1–2 mg subcutaneous once or twice per week (e.g., Monday and Thursday)
- Higher dosing: Some protocols use 2–4 mg per week during loading phases
- Popular stack: CJC-1295 with DAC 1–2 mg/week + Ipamorelin 100–300 μg daily or nightly
- Cycles: 8–16 weeks on, followed by 4+ weeks off to prevent potential desensitization
Safety Profile and Side Effects
CJC-1295 with DAC is generally well-tolerated at research doses.
Common side effects:
- Mild water retention
- Injection-site reactions
- Increased hunger (when stacked with GHRPs)
- Possible mild joint discomfort at higher doses
Monitoring recommended: IGF-1, fasting glucose, insulin sensitivity, and prolactin with prolonged use. Contraindicated in active cancer or uncontrolled endocrine disorders.
CJC-1295 with DAC vs No DAC vs Exogenous GH – Quick Comparison
| Aspect | CJC-1295 with DAC | CJC-1295 no DAC | Exogenous GH |
|---|---|---|---|
| Half-life | ~6–8 days | ~30 minutes | ~2–4 hours |
| GH Pattern | Sustained elevation | Sharp, natural pulses | Continuous |
| Dosing Frequency | 1–2× per week | 1–3× daily | Daily |
| Best For | Convenience | Physiologic pulsing | High-dose anabolism |
| IGF-1 Elevation | Sustained | Pulsatile | Sustained |
| FDA Status | Not approved | Not approved | Approved (specific uses) |
FAQ – Frequently Asked Questions
What is the difference between CJC-1295 with DAC and no DAC? With DAC provides long-lasting sustained GH elevation with infrequent dosing. No DAC creates sharp, natural pulses and requires more frequent administration.
Can CJC-1295 with DAC be used alone? Yes, but most users report better results when stacked with a GHRP such as Ipamorelin.
How long until results are seen? GH and IGF-1 levels rise within days; noticeable improvements in recovery, body composition, and sleep typically appear within 2–6 weeks.
Does CJC-1295 with DAC suppress natural GH production? It stimulates the body’s own production and generally preserves feedback mechanisms better than high-dose exogenous GH.
Is CJC-1295 with DAC FDA approved? No. It is available only as a research chemical or through compounding pharmacies under physician supervision.
Summary
CJC-1295 with DAC is a long-acting GHRH analog that delivers sustained GH and IGF-1 elevation with the convenience of 1–2 weekly injections. It is widely researched and used in stacks for muscle growth, fat loss, recovery, and anti-aging protocols. While it lacks large-scale approved clinical indications, it offers a practical alternative to daily pulsing peptides. As with all compounds in this library, CJC-1295 with DAC is not an approved drug and should only be considered under qualified medical supervision with appropriate lab monitoring.
For Laboratory Research Use View CJC-1295 with DAC →
Disclaimer This overview is strictly educational and based on publicly available scientific literature and regulatory information as of April 2026. It does not constitute medical advice, endorsement, or encouragement of use. Always consult a qualified healthcare professional and comply with all applicable laws and regulations.